Latest Headlines

Latest Headlines

Danaher adds to its diagnostics biz, but deal may not be large enough for the Street

Once known as a serial acquirer, Danaher broke its big acquisition drought with the addition of Siemen's clinical microbiology unit to its Beckman Coulter division. The price was not disclosed, but company officials described it as the largest deal in two years during the quarterly earnings call on the heels of the July 17 announcement. 

Researchers develop real-time, 'nanojuice'-enabled imaging method for gut

Conventional imaging methods don't work so well in the gut, the site of irritable bowel syndrome, celiac disease and Crohn's disease among others. Researchers at the University of Buffalo say they have solved the problem, albeit in animal studies.

Senators call on White House to release FDA guidance on lab-developed tests

Five senate Democrats called for the White House Office of Management and Budget to release a long-sequestered FDA draft guidance on laboratory developed tests for public comment. In a letter to OMB acting director Brian Deese, they urged him to release the proposed regulation "to ensure appropriate and efficient oversight of diagnostic tools can move forward in an open and transparent manner."

Cancer Dx company Definiens adds $20.4M venture round

Definiens secured financing to grow its existing imaging-analysis business and to expand into tissue diagnostics. New investor Wellington Partners led the €15 million ($20.4 million) financing and joined the board.

World's tiniest blood glucose monitor launches for iPhone, Android

Cell phones are indispensable for many. Now a plug-in meter that's about the size of a quarter makes it easier to track blood sugar on a mobile device. The newly launched iHealth Align is the world's smallest FDA-approved blood glucose monitor, according to its maker, iHealth.

AbbVie to co-promote hep C diagnostic

AbbVie will have exclusive promotion rights to the sole FDA-approved point-of-care test for the hepatitis C virus, under a co-promotion agreement with OraSure Technologies, maker of the OraQuick HCV Rapid Test.

Study demystifies U.S. diagnostic test costs

The data are an analysis of the costs paid through employer-sponsored benefits for four common outpatient services including a lipid panel, a CT scan of the head or brain, and an MRI of the lower back. It was conducted by healthcare consultancy Castlight Health.

FDA approves Auxogyn embryo test for IVF procedures

The FDA gave de novo approval to Menlo Park-based Auxogyn's Eeva System, a fertility-enhancing diagnostic test currently available in Europe and Canada.  

FDA clears new model of sleep apnea diagnostic device

The FDA approved the latest version of WatchPat, a home sleep diagnostic device.

Kleiner Perkins, TPG-backed heart transplant monitor company files for $50M IPO

Molecular diagnostic company CareDx hopes a new name, a new deal and an IPO for up to $50 million will give it new life. The company has marketed blood-based test AlloMap to monitor heart transplant patients since 2005 but has yet to breakeven.